Hail stentors! How the hail do I stop the warfarin?

Interest in coronary stenting has exploded since the publication of several large, randomized trials, and (due to the rapidity of patient recruitment into non-randomized trials) volumes of data are quickly abandoning "old standards" of patient selection, operative technique, and postoperative anticoagulation management. In this editorial, suggestions are offered to help clinicians take the leap from outdated Food and Drug Administration-guided regulations to off-label use and withholding of anticoagulation.